ConvaTec Group PLC (LON:CTEC)

Intercept Pharmaceuticals Revenue

ConvaTec Group had revenue of $1.18B USD in the half year ending June 30, 2025, with 11.79% growth. This brings the company's revenue in the last twelve months to $2.36B, up 7.06% year-over-year. In the year 2024, ConvaTec Group had annual revenue of $2.29B with 6.85% growth.

• Revenue (ttm): $2.36B
• Revenue Growth: +7.06%
• P/S Ratio: 2.75
• Revenue / Employee: $224.59K
• Employees: 10,489
• Market Cap: 4.72B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.29B	146.80M	6.85%
Dec 31, 2023	2.14B	69.90M	3.37%
Dec 31, 2022	2.07B	34.20M	1.68%
Dec 31, 2021	2.04B	144.00M	7.60%
Dec 31, 2020	1.89B	67.10M	3.67%